Home > Financial Ratios > ALKEM LABORATORIES

ALKEM LABORATORIES
Core EBITDA Growth

    Back to All Ratios
ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ALKEM LABORATORIES
Please provide your vote to see the results

ALKEM LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.5940.03-17.601.8437.90

What is the latest Core EBITDA Growth ratio of ALKEM LABORATORIES ?

The latest Core EBITDA Growth ratio of ALKEM LABORATORIES is 17.59 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.59
Mar202440.03
Mar2023-17.60
Mar20221.84
Mar202137.90

How is Core EBITDA Growth of ALKEM LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 17.59
-56.06
Mar2024 40.03
Positive
Mar2023 -17.6
Negative
Mar2022 1.84
-95.15
Mar2021 37.9 -

Other Financial Ratios of ALKEM LABORATORIES


Compare Core EBITDA Growth ratio of peers of ALKEM LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALKEM LABORATORIES ₹66,259.0 Cr -1.8% -1.9% 19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,628.0 Cr 3.5% 5.6% 11.9% Stock Analytics
DIVIS LABORATORIES ₹167,975.0 Cr -1.3% 4.5% 16.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,804.0 Cr -0.7% 6.9% 47.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,829.0 Cr 1.3% 5.1% 17.5% Stock Analytics
CIPLA ₹106,768.0 Cr -1.9% -0.3% -6% Stock Analytics


ALKEM LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALKEM LABORATORIES

-1.8%

-1.9%

19.6%

SENSEX

-4.1%

-5.8%

5.8%


You may also like the below Video Courses